In addition, we provide important new insights into how crosstalk between TGF-β and H-Ras signaling induces EMT and tumor metastasis in human lung cancer cells through activation of JMJD3, and highlight that JMJD3 might be a new therapeutic target against Ras-activated lung cancer cells. Here, KDM6B is linked to lung carcinoma.